| ID | Sequence | Length | GC content |
|---|---|---|---|
| GGCGACGACCAGAAGGGGCCCAAGAGAGGGGGCGAGCGACCGAGCGCCG… | 3177 nt | 0.3812 | |
| GGCGACGACCAGAAGGGGCCCAAGAGAGGGGGCGAGCGACCGAGCGCCG… | 3396 nt | 0.3919 | |
| GCUUCUCCAUUCUGGUGUGAUCCAGGAACAGCUGUCUUCCAGCUCUGAA… | 3030 nt | 0.3620 | |
| GCUUCUCCAUUCUGGUGUGAUCCAGGAACAGCUGUCUUCCAGCUCUGAA… | 3099 nt | 0.3675 | |
| GGCGACGACCAGAAGGGGCCCAAGAGAGGGGGCGAGCGACCGAGCGCCG… | 3041 nt | 0.3673 | |
| GGCGACGACCAGAAGGGGCCCAAGAGAGGGGGCGAGCGACCGAGCGCCG… | 3465 nt | 0.3962 | |
| GAGUGUGAGCGGCGCCUGCUCAGGGUAGAUAGCUGAGGGCGGGGGUGGA… | 3091 nt | 0.3675 | |
| GCUCUAAUUCUCUGCACCUUCUCAAGCAUUGUGCAGAUUGGUUUUCUGG… | 2984 nt | 0.3515 | |
| GGCGACGACCAGAAGGGGCCCAAGAGAGGGGGCGAGCGACCGAGCGCCG… | 3312 nt | 0.3901 |
Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Alternatively spliced transcripts encoding different isoforms have been identified for this gene. [provided by RefSeq, Feb 2016]
No relevant information is available at the moment.